{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:21:30Z","timestamp":1785162090598,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.SUMS.REC.92-01-01-6693)"],"award-info":[{"award-number":["IR.SUMS.REC.92-01-01-6693)"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3554-6","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T15:02:39Z","timestamp":1564498959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7060-469X","authenticated-orcid":false,"given":"Jamshid","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Biuseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"3554_CR1","first-page":"70","volume":"8","author":"J Ahmadi","year":"2014","unstructured":"Ahmadi J, Ahmadi N, Soltani F, Bayat F. Gender differences in depression scores of Iranian and German medical students. Iran J Psychiatry Behav Sci. 2014;8:70\u20133.","journal-title":"Iran J Psychiatry Behav Sci."},{"key":"3554_CR2","first-page":"50","volume":"16","author":"M Mackay-Smith","year":"2015","unstructured":"Mackay-Smith M, Ahmadi J, Pridmore S. Suicide in shooting galleries. ASEAN J Psychiatry. 2015;16:50\u20136.","journal-title":"ASEAN J Psychiatry"},{"key":"3554_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2466\/PR0.89.6.363-365","volume":"89","author":"J Ahmadi","year":"2001","unstructured":"Ahmadi J, Fakoor A, Pezeshkian P, Khoshnood R, Malekpour A. Substance use among Iranian psychiatric inpatients. Psychol Rep. 2001;89:363\u20135.","journal-title":"Psychol Rep"},{"key":"3554_CR4","doi-asserted-by":"publisher","first-page":"005","DOI":"10.4172\/2155-6105.S6-005","volume":"S6","author":"J Ahmadi","year":"2013","unstructured":"Ahmadi J, Ahmed MG. Dubai medical college students\u2019 attitudes towards substance use. J Addict Res Ther. 2013;S6:005. \n                    https:\/\/doi.org\/10.4172\/2155-6105.S6-005\n                    \n                  .","journal-title":"J Addict Res Ther"},{"key":"3554_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/10550490802545174","volume":"18","author":"J Ahmadi","year":"2009","unstructured":"Ahmadi J, Kampman K, Osline DM, Pettinati HM, Dackis C, Sparkman T. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Am J Addict. 2009;18:81\u20136.","journal-title":"Am J Addict"},{"key":"3554_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/10550490701755999","volume":"17","author":"J Ahmadi","year":"2008","unstructured":"Ahmadi J, Kampman K, Dackis C, Sparkman T, Pettinati H. Cocaine withdrawal symptoms identify type B cocaine-dependent patients. Am J Addict. 2008;17:60\u20134.","journal-title":"Am J Addict"},{"key":"3554_CR7","first-page":"616","volume-title":"Kaplan and Sadock\u2019s Synopsis of Psychiatry: Substance Use and Addictive Disorders","year":"2015","unstructured":"Sadock B, Sadock V, Ruiz P, editors. Kaplan and Sadock\u2019s Synopsis of Psychiatry: Substance Use and Addictive Disorders. Chapter 20 ed. Philadelphia: Lippincott Williams and Wilkins; 2015. p. 616\u201393.","edition":"Chapter 20"},{"key":"3554_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1521-0391.2011.00132.x","volume":"20","author":"J Ahmadi","year":"2011","unstructured":"Ahmadi J, Keshtkar M, Pridmore S. Methamphetamine induced synesthesia: a case report. Am J Addict. 2011;20:306.","journal-title":"Am J Addict"},{"key":"3554_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13063-017-2007-3.1038\/clpt.1994.71","volume":"18","author":"J Ahmadi","year":"2017","unstructured":"Ahmadi J, Razeghian Jahromi L. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial. Trials. 2017;18:259. \n                    https:\/\/doi.org\/10.1186\/s13063-017-2007-3.1038\/clpt.1994.71\n                    \n                  .","journal-title":"Trials"},{"key":"3554_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BJMMR\/2015\/19334","volume":"10","author":"J Ahmadi","year":"2015","unstructured":"Ahmadi J. The effect of buprenorphine and bupropion in the treatment of methamphetamine dependency and craving. Br J Med Med Res. 2015;10:1\u20134.","journal-title":"Br J Med Med Res"},{"key":"3554_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4103\/0253-7176.211765","volume":"39","author":"J Ahmadi","year":"2017","unstructured":"Ahmadi J, Sefidfard M. Anxiety treatment of opioid dependent patients with buprenorphine: A randomized, double-blind, clinical trial. Indian J Psychol Med. 2017;39:445\u20139.","journal-title":"Indian J Psychol Med"},{"key":"3554_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00213-006-0494-0","volume":"188","author":"WF Hoffman","year":"2006","unstructured":"Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology. 2006;188:162\u201370.","journal-title":"Psychopharmacology"},{"key":"3554_CR13","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.biopsych.2006.07.031","volume":"61","author":"R Salo","year":"2007","unstructured":"Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, et al. Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry. 2007;61:1272\u201380.","journal-title":"Biol Psychiatry"},{"key":"3554_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.21767\/2471-853X.100012","volume":"2","author":"J Ahmadi","year":"2016","unstructured":"Ahmadi J. Methylphenidate in the treatment of methamphetamine withdrawal craving: a novel outcome. J Drug Abuse. 2016;2:12.","journal-title":"J Drug Abuse"},{"key":"3554_CR15","doi-asserted-by":"publisher","first-page":"044","DOI":"10.17352\/2455-3484.000011","volume":"1","author":"J Ahmadi","year":"2016","unstructured":"Ahmadi J. Fast treatment of methamphetamine related anxiety and depressive disorders: a novel approach. J Addict Med Ther Sci. 2016;1:044\u20136. \n                    https:\/\/doi.org\/10.17352\/2455-3484.000011\n                    \n                  .","journal-title":"J Addict Med Ther Sci"},{"key":"3554_CR16","first-page":"51","volume":"3","author":"J Ahmadi","year":"2016","unstructured":"Ahmadi J. Recurrent psychosis related to methamphetamine. J Harmoniz Res Med and HlthSci. 2016;3:51\u20135.","journal-title":"J Harmoniz Res Med and HlthSci."},{"key":"3554_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-642-28720-6_143","volume":"13","author":"DM Lovinger","year":"2013","unstructured":"Lovinger DM, Roberto M. Synaptic effects induced by alcohol. Curr Top Behav Neurosci. 2013;13:31\u201386.","journal-title":"Curr Top Behav Neurosci"},{"key":"3554_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/187152710790966704","volume":"9","author":"LA Ray","year":"2010","unstructured":"Ray LA, Chin PF, Miotto K. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS Neurol Disord Drug Targets. 2010;9:13\u201322.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3554_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature10954","volume":"485","author":"A Manglik","year":"2012","unstructured":"Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, et al. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature. 2012;485:321\u20136.","journal-title":"Nature"},{"key":"3554_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14886","volume":"524","author":"W Huang","year":"2015","unstructured":"Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, et al. Structural insights into micro-opioid receptor activation. Nature. 2015;524:315\u201321.","journal-title":"Nature"},{"key":"3554_CR21","doi-asserted-by":"publisher","first-page":"21548","DOI":"10.1038\/srep21548","volume":"6","author":"T Kaserer","year":"2016","unstructured":"Kaserer T, Lantero A, Schmidhammer H, Spetea M, Schuster D. Mu opioid receptor: novel antagonists and structural modeling. Sci Rep. 2016;6:21548.","journal-title":"Sci Rep"},{"issue":"suppl 1","key":"3554_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/11536020-000000000-00000","volume":"30","author":"E Moratti","year":"2010","unstructured":"Moratti E, Kashanpour H, Lombardelli T, Maisto M. Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy. Clin Drug Investig. 2010;30(suppl 1):3\u201311.","journal-title":"Clin Drug Investig"},{"key":"3554_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jsat.2013.01.003","volume":"45","author":"H Uosukainen","year":"2013","unstructured":"Uosukainen H, Pentik\u00e4inen H, Tacke U. The effect of an electronic medicine dispenser on diversion of buprenorphine naloxone experience from a medium-sized Finnish city. J Subst Abus Treat. 2013;45:143\u20137.","journal-title":"J Subst Abus Treat"},{"key":"3554_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1200\/JCO.2013.53.1079","volume":"32","author":"GW Pasternak","year":"2014","unstructured":"Pasternak GW. Opiate pharmacology and relief of pain. J Clin Oncol. 2014;32:1637\u20139.","journal-title":"J Clin Oncol."},{"key":"3554_CR25","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.2174\/13816128113199990362","volume":"19","author":"M Spetea","year":"2013","unstructured":"Spetea M, Asim MF, Wolber G, Schmidhammer H. The \u03bc opioid receptor and ligands acting at the \u03bc opioid receptor, as therapeutics and potential therapeutics. Curr Pharm Des. 2013;19:7415\u201334.","journal-title":"Curr Pharm Des."},{"key":"3554_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.drugalcdep.2012.05.025","volume":"126","author":"MR Lofwall","year":"2012","unstructured":"Lofwall MR, Havens JR. Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine. Drug Alcohol Depend. 2012;126:379\u201383.","journal-title":"Drug Alcohol Depend"},{"key":"3554_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","volume":"142","author":"TJ Cicero","year":"2014","unstructured":"Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. Factors contributing to the rise of buprenorphine misuse: 2008\u20132013. Drug Alcohol Depend. 2014;142:98\u2013104.","journal-title":"Drug Alcohol Depend"},{"key":"3554_CR28","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jamainternmed.2013.9059","volume":"173","author":"RE Clark","year":"2013","unstructured":"Clark RE, Baxter JD. Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good? JAMA Intern Med. 2013;173:1571\u20132.","journal-title":"JAMA Intern Med."},{"key":"3554_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jsat.2011.04.008","volume":"41","author":"MR Lofwall","year":"2011","unstructured":"Lofwall MR, Wunsch MJ, Nuzzo PA, Walsh SL. Efficacy of continuing medical education to reduce the risk of buprenorphine diversion. J Subst Abuse Treat. 2011;41:321\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"3554_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1521-0391.2012.00335.x","volume":"22","author":"Amy Yang","year":"2013","unstructured":"Yang A, Arfken CL, Johanson CE. Steps physicians report taking to reduce diversion of buprenorphine. Am J Addict. 2013;22:184\u20137.","journal-title":"The American Journal on Addictions"},{"key":"3554_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","volume":"39","author":"CL Arfken","year":"2010","unstructured":"Arfken CL, Johanson CE, Di Menza S, Schuster CR. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national survey of physicians. J Subst Abus Treat. 2010;39:96\u2013104.","journal-title":"J Subst Abus Treat"},{"key":"3554_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1521-0391.2009.00026.x","volume":"19","author":"MR Lofwall","year":"2010","unstructured":"Lofwall MR, Wunsch MJ, Walsh SL. Pharmacy willingness to partner with office-based opioid dependence treatment providers in conducting random buprenorphine pill counts. Am J Addict. 2010;19:195\u20136.","journal-title":"Am J Addict"},{"key":"3554_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.15288\/jsad.2015.76.644","volume":"76","author":"HK Knudsen","year":"2015","unstructured":"Knudsen HK. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: a state-level analysis. J Stud Alcohol Drugs. 2015;76:644\u201354.","journal-title":"J Stud Alcohol Drugs"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3554-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3554-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3554-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:08:57Z","timestamp":1595977737000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3554-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3554"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3554-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"3 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided written informed consent, and the study was approved and monitored by the ethics committee of Shiraz University of Medical Sciences, which adheres to the Declaration of Helsinki Ethical Principles for Medical Research involving human subjects (IR.SUMS.REC.92\u201301-01-6693). This study was granted by the Vice Chancellery for Research, Shiraz University of Medical Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}